世界の非ステロイド性抗炎症薬（NSAID）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z10068 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥494,160 (USD3,480)	▷ お問い合わせ
Multi User	￥741,240 (USD5,220)	▷ お問い合わせ
Corporate User	￥988,320 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、非ステロイド性抗炎症薬（NSAID）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。非ステロイド性抗炎症薬（NSAID）の種類別市場規模（サリチル酸、プロピオン酸誘導体、酢酸誘導体、エノール酸（オキシカム）誘導体、アントラニル酸誘導体（フェナム酸）、選択的COX-2阻害剤（コキシブ）、スルホンアニリド）、用途別市場規模（人間、動物、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・非ステロイド性抗炎症薬（NSAID）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer、Ecotrin、Generic、St. Joseph、Elanco、Zoetis、Boehringer Ingelheim、Merial、Merck Animal Health ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：サリチル酸、プロピオン酸誘導体、酢酸誘導体、エノール酸（オキシカム）誘導体、アントラニル酸誘導体（フェナム酸）、選択的COX-2阻害剤（コキシブ）、スルホンアニリド ・用途別分析2016年-2026年：人間、動物、その他 ・非ステロイド性抗炎症薬（NSAID）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・非ステロイド性抗炎症薬（NSAID）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・非ステロイド性抗炎症薬（NSAID）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・非ステロイド性抗炎症薬（NSAID）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・非ステロイド性抗炎症薬（NSAID）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Non-steroidal Anti-inflammatory Drugs (NSAID) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Non-steroidal Anti-inflammatory Drugs (NSAID) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Non-steroidal Anti-inflammatory Drugs (NSAID) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Non-steroidal Anti-inflammatory Drugs (NSAID) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Salicylates
Propionic acid derivatives
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides

Market segment by Application can be divided into
Human
Animals
Others

The key market players for global Non-steroidal Anti-inflammatory Drugs (NSAID) market are listed below:
Bayer
Ecotrin
Generic
St. Joseph
Elanco
Zoetis
Boehringer Ingelheim
Merial
Merck Animal Health

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Salicylates
1.2.3 Propionic acid derivatives
1.2.4 Acetic acid derivatives
1.2.5 Enolic acid (Oxicam) derivatives
1.2.6 Anthranilic acid derivatives (Fenamates)
1.2.7 Selective COX-2 inhibitors (Coxibs)
1.2.8 Sulfonanilides
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Human
1.3.3 Animals
1.3.4 Others
1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size & Forecast
1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Value (2016-2026))
1.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume (2016-2026)
1.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2016-2026) & (USD/Unit)
1.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity Analysis
1.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Total Production Capacity (2016-2026)
1.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
1.6.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
1.6.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Ecotrin
2.2.1 Ecotrin Details
2.2.2 Ecotrin Major Business
2.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Generic
2.3.1 Generic Details
2.3.2 Generic Major Business
2.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 St. Joseph
2.4.1 St. Joseph Details
2.4.2 St. Joseph Major Business
2.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Elanco
2.5.1 Elanco Details
2.5.2 Elanco Major Business
2.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Zoetis
2.6.1 Zoetis Details
2.6.2 Zoetis Major Business
2.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business
2.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Merial
2.8.1 Merial Details
2.8.2 Merial Major Business
2.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Merck Animal Health
2.9.1 Merck Animal Health Details
2.9.2 Merck Animal Health Major Business
2.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturer
3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Non-steroidal Anti-inflammatory Drugs (NSAID)
3.4 Market Concentration Rate
3.4.1 Top 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturer Market Share
3.4.2 Top 6 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturer Market Share
3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Non-steroidal Anti-inflammatory Drugs (NSAID) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region
4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Region (2016-2026)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2016-2026)
4.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2016-2026)
4.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2016-2026)
4.4 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2016-2026)
4.5 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2016-2026)
4.6 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Type (2016-2026)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2016-2026)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Application (2016-2026)
6.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2016-2026)
6.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2026)
7.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2026)
7.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
7.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Country (2016-2026)
7.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2026)
8.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2026)
8.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
8.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Country (2016-2026)
8.3.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2026)
9.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2026)
9.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region
9.3.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2026)
10.2 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2026)
10.3 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
10.3.1 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Country (2016-2026)
10.3.2 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2026)
11.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2026)
11.3 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
11.3.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Typical Distributors
12.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 6. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Ecotrin Basic Information, Manufacturing Base and Competitors
Table 8. Ecotrin Major Business
Table 9. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 10. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Generic Basic Information, Manufacturing Base and Competitors
Table 12. Generic Major Business
Table 13. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 14. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. St. Joseph Basic Information, Manufacturing Base and Competitors
Table 16. St. Joseph Major Business
Table 17. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 18. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Elanco Basic Information, Manufacturing Base and Competitors
Table 20. Elanco Major Business
Table 21. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 22. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Zoetis Basic Information, Manufacturing Base and Competitors
Table 24. Zoetis Major Business
Table 25. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 26. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 28. Boehringer Ingelheim Major Business
Table 29. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 30. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merial Basic Information, Manufacturing Base and Competitors
Table 32. Merial Major Business
Table 33. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 34. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 36. Merck Animal Health Major Business
Table 37. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 38. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Non-steroidal Anti-inflammatory Drugs (NSAID), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Non-steroidal Anti-inflammatory Drugs (NSAID) Production Site of Key Manufacturer
Table 44. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2016-2021e) & (K Units)
Table 45. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2021-2026) & (K Units)
Table 46. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021e) & (K Units)
Table 49. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (K Units)
Table 50. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2016-2021e) & (USD/Unit)
Table 53. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2021-2026) & (USD/Unit)
Table 54. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021e) & (K Units)
Table 55. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (K Units)
Table 56. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2016-2021e) & (USD/Unit)
Table 59. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2021-2026) & (USD/Unit)
Table 60. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2016-2021e) & (K Units)
Table 61. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2026) & (K Units)
Table 62. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021e) & (K Units)
Table 65. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (K Units)
Table 66. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021e) & (K Units)
Table 67. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (K Units)
Table 68. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2026) & (K Units)
Table 70. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (K Units)
Table 74. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (K Units)
Table 84. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2016-2021e) & (K Units)
Table 85. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2026) & (K Units)
Table 86. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021e) & (K Units)
Table 89. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (K Units)
Table 90. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021e) & (K Units)
Table 91. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Non-steroidal Anti-inflammatory Drugs (NSAID) Typical Distributors
Table 103. Non-steroidal Anti-inflammatory Drugs (NSAID) Typical Customers
List of Figures
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Picture
Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type in 2020
Figure 3. Salicylates
Figure 4. Propionic acid derivatives
Figure 5. Acetic acid derivatives
Figure 6. Enolic acid (Oxicam) derivatives
Figure 7. Anthranilic acid derivatives (Fenamates)
Figure 8. Selective COX-2 inhibitors (Coxibs)
Figure 9. Sulfonanilides
Figure 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application in 2020
Figure 11. Human
Figure 12. Animals
Figure 13. Others
Figure 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (2016-2026) & (K Units)
Figure 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (2016-2026) & (K Units)
Figure 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
Figure 39. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
Figure 40. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
Figure 41. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturer in 2020
Figure 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturer in 2020
Figure 43. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2016-2026)
Figure 47. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2016-2026)
Figure 48. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2016-2026) & (USD Million)
Figure 49. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2016-2026) & (USD Million)
Figure 51. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2016-2026) & (USD Million)
Figure 53. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2026)
Figure 54. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2016-2026)
Figure 55. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2016-2026) & (USD/Unit)
Figure 56. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2026)
Figure 57. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2016-2026)
Figure 58. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2016-2026) & (USD/Unit)
Figure 59. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2016-2026)
Figure 60. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2016-2026)
Figure 61. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2026)
Figure 62. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2026)
Figure 63. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2016-2026)
Figure 64. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2016-2026)
Figure 65. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2026)
Figure 66. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2026)
Figure 71. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2016-2026)
Figure 72. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2016-2026)
Figure 73. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2026)
Figure 74. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source

---